Phase IIa, double-blind, randomized, placebo-controlled study of the efficacy and safety of SOM3335 in Huntington`s disease (HD) patients with chorea movements. Phase IIa, double-blind, randomized, placebo-controlled study of the efficacy and safety of SOM3335 ...
Phase IIa, double-blind, randomized, placebo-controlled study of the efficacy and safety of SOM3335 in Huntington`s disease (HD) patients with chorea movements. Phase IIa, double-blind, randomized, placebo-controlled study of the efficacy and safety of SOM3335 ...
Chorea movements associated with Huntington's Disease MedDRA version: 20.0;Level: LLT;Classification code 10020469;Term: Huntington's chorea;System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] Chorea movements associated with Huntington's Disease MedDRA version: 20.0;Level: LLT;Classification ...